为您找到相关结果约500个

你是不是要搜索 期刊Trastuzumab+emtansine+(T-DM1)+in+patients+with+HER2-positive+metastatic+breast+cancer+and+brain+metastases：+exploratory+final+analysis+of+cohort+1+from+KAMILLA，+a+single-arm+phase+IIIb+clinical+trial. 点击跳转

Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial

Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primaryresults from the KAMILLA study cohort 1

Final results of the global and Asia cohorts of KAMILLA, a phase IIIB safety trial of trastuzumab emtansinein patients with HER2-positive advanced breast cancer

Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial

Safety of trastuzumab emtansine (T-DM1) in HER2-positive advanced breast cancer (BC) patients (pts):Primary results from KAMILLA study cohort 1.

Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in PatientsWith Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer A Phase 1 and Randomized Phase2 Trial

TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASESFROM HER-2 POSITIVE BREAST CANCER (TUTOR): A MULTICENTER PHASE 1 CLINICAL TRIAL

Trastuzumab Emtansine (T-DM1) Plus S-1 in Patients with Trastuzumab-Pretreated HER2-Positive Advancedor Metastatic Breast Cancer: A Phase Ib Study

Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Finalanalysis of MetaPHER, a phase IIIb single-arm safety study

Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer(Thelma): A Single-Arm, Multicenter, Phase Ib Trial

Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breastcancer

The evolving role of trastuzumab emtansine (T-DM1) in HER2-positive breast cancer with brain metastases

Brain metastases and ado-trastuzumab emtansine (TDM-1) treatment in HER2 positive metastatic patients: an Italian multicenter analysis

Trastuzumab emtansine vs lapatinib and capecitabine in HER2-positive metastatic breast cancer brain metastases

Safety and efficacy of trastuzumab emtansine (T-DM1) in 399 patients with central nervous system metastases: Exploratory subgroup analysis from the KAMILLA study

为您找到相关结果约500个

共500条页码: 1/34页15条/页